Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis. Menge T, Dubey D, Warnke C, Hartung H-P, Stüve O Expert Rev Neurother. 2016 Oct; 16(10):1131-9. Epub 2016 Sep 01. PMID: 27552111. Abstract CommentRecommendBookmarkWatch
